SASarah Jane Arnup

Sarah Jane Arnup

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sarah Jane Arnup has a total of 243 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development of a tool to assess the risk of bias in statistical simulation studies: study protocol

    by Sarah J Arnup, Simon L Turner, Matthew J Page, Elizabeth Korevaar, Steve McDonald, Julian Pt Higgins, Joanne E McKenzie

    Background Statistical simulation studies are the principal methodology for examining the performance of statistical methods. Findings from statistical simulation studies guide researchers in their statistical decision making, and inform evidence syntheses of statistical simulation studies, so should provide a fair representation of how the methods are expected to perform. Objectives To develop a tool to assess whether statistical simulation studies provide a fair representation of how statistical methods are expected to perform. Methods We will undertake a multi-step process to develop a domain-based tool with signalling questions. The project team will consist of a core working group and an international advisory group. We will hold virtual meetings with the advisory group to agree on the scope and content of the tool. We will conduct systematic reviews and cited reference searches (forward and backward citations) to develop an evidence base to inform domains and signalling questions. An initial set of domains will be agreed on with the advisory group. We will then undertake a survey of methodologists and statisticians with expertise in statistical simulation design and intended users of the tool, to seek their views on which domains are most important. We will propose signalling questions for each domain and revise the domains with feedback from the advisory group until domains are agreed. We will pilot the tool with intended users such as consulting statisticians and systematic reviewers of findings from simulation studies. The developed tool and guidance documentation will be published in an open-access journal and disseminated via conferences and workshops. This protocol has been registered on the Open Science Framework (OSF) on June 2 2026, (Registration DOI: https://doi.org/10.17605/OSF.IO/DW4SM). 1

  • Open Access

    Reporting of cluster randomised crossover trials: extension of the CONSORT 2010 statement with explanation and elaboration

    by Joanne E McKenzie, Monica Taljaard, Karla Hemming, Sarah J Arnup, Bruno Giraudeau, Sandra Eldridge, Richard Hooper, Brennan C Kahan, Tianjing Li, David Moher, et al.

    This article presents the CONSORT (consolidated standards of reporting trials) extension for cluster randomised crossover trials. A cluster randomised crossover trial involves randomisation of groups of individuals (known as clusters) to different sequences of interventions over time. The design has gained popularity in settings where cluster randomisation is required because it can largely overcome the loss in power due to clustering in parallel cluster trials. However, the design has many methodological complexities, requiring tailored reporting guidance. The guideline was developed using a survey and in-person consensus meeting, informed by a systematic review examining the quality of reporting in cluster randomised crossover trials and relevant CONSORT statements for individual, crossover, cluster, and stepped wedge designs. This article also provides recommended reporting items, along with explanations and examples.


  • Open Access

    Reporting of cluster randomised crossover trials 2023: extension of the CONSORT 2010 statement with explanation and elaboration

    by Joanne McKenzie, Monica Taljaard, Karla Hemming, Sarah Arnup, Bruno Giraudeau, Sandra Eldridge, Richard Hooper, Brennan Kahan, Tianjing Li, David Moher, et al.

    In this report we present the Consolidated Standards of Reporting Trials (CONSORT) extension for the cluster randomised crossover (CRXO) trial. A CRXO trial involves randomisation of groups of individuals (‘clusters’) to different sequences of treatments over time. The design has gained popularity in settings where cluster randomisation is required as it can largely overcome the loss in power due to clustering in parallel cluster trials. However, the design has many methodological complexities, requiring tailored reporting guidance. The guideline was developed using a survey and in-person consensus meeting, informed by a systematic review examining the quality of reporting in CRXO trials and relevant CONSORT statements for individual, crossover, cluster and stepped-wedge designs. We provide recommended reporting items, along with explanations and examples.


  • Open Access

    Serious Injury in Metropolitan and Regional Victoria: Exploring Travel to Treatment and Utilisation of Post-Discharge Health Services by Injury Type

    by Jemma Keeves, Belinda Gabbe, Sarah Arnup, Christina Ekegren, Ben Beck

    This study aimed to describe regional variations in service use and distance travelled to post-discharge health services in the first three years following hospital discharge for people with transport-related orthopaedic, brain, and spinal cord injuries. Using linked data from the Victorian State Trauma Registry (VSTR) and Transport Accident Commission (TAC), we identified 1597 people who had sustained transport-related orthopaedic, brain, or spinal cord injuries between 2006 and 2016 that met the study inclusion criteria. The adjusted odds of GP service use for regional participants were 76% higher than for metropolitan participants in the orthopaedic and traumatic brain injury (TBI) groups. People with spinal cord injury (SCI) living in regional areas had 72% lower adjusted odds of accessing mental health, 76% lower adjusted odds of accessing OT services, and 82% lower adjusted odds of accessing physical therapies compared with people living in major cities. People with a TBI living in regional areas on average travelled significantly further to access all post-discharge health services compared with people with TBI in major cities. For visits to medical services, the median trip distance for regional participants was 76.61 km (95%CI: 16.01–132.21) for orthopaedic injuries, 104.05 km (95% CI: 51.55–182.78) for TBI, and 68.70 km (95%CI: 8.34–139.84) for SCI. Disparities in service use and distance travelled to health services exist between metropolitan Melbourne and regional Victoria following serious injury.


  • Open Access

    Modest decrease in severity of obesity in adolescence associates with low arterial stiffness

    by Christoph Saner, Tomi T. Laitinen, Joel Nuotio, Sarah J. Arnup, Brooke E. Harcourt, Siroon Bekkering, Zoe McCallum, Kung-Ting Kao, Marco Janner, Costan G. Magnussen, et al.


  • Open Access

    Exposure to adversity and inflammatory outcomes in mid and late childhood

    by Meredith O'COnnor, Anne-Louise Ponsonby, Fiona Collier, Richard Liu, Peter D. Sly, Peter Azzopardi, Kate Lycett, Sharon Goldfeld, Sarah J. Arnup, David Burgner, et al.


  • Top Cited Papers
    Open Access

    Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial

    by Mary Ellen McCann, Jurgen C de Graaff, Liam Dorris, Nicola Disma, Davinia Withington, Graham Bell, Anneke Grobler, Robyn Stargatt, Rodney W Hunt, Suzette J Sheppard, et al.


  • Enrollment challenges in multicenter, international studies: The example of the GAS trial

    by Katherine R. Gentry, Sarah J. Arnup, Nicola Disma, Liam Dorris, Jurgen C. de Graaff, Agnes Hunyady, Neil S. Morton, Davinia E. Withington, Mary Ellen McCann, Andrew J. Davidson, et al.

    Summary: Introduction: Randomized trials are important for generating high‐quality evidence, but are perceived as difficult to perform in the pediatric population. Thus far there has been poor characterization of the barriers to conducting trials involving children, and the variation in these barriers between countries remains undescribed. The General Anesthesia compared to Spinal anesthesia (GAS) trial, conducted in seven countries between 2007 and 2013, provides an opportunity to explore these issues.Methods: We undertook a descriptive analysis to evaluate the reasons for variation in enrollment between countries in the GAS trial, looking specifically at the number of potential subjects screened, and the subsequent application of four exclusion criteria that were applied in a hierarchical order.Results: A total of 4023 patients were screened by 28 centers in seven countries. Australia and the USA screened the most subjects, accounting for 84% of all potential trial participants. The percentage of subjects eliminated from the screened pool by each exclusion criterion varied between countries. Exclusion due to a predefined condition (H1) eliminated only 5% of potential subjects in Italy and the UK, but 37% in Canada. Exclusions due to a contraindication or a physician's refusal most impacted enrollment in Australia and the USA. The patient being “too large for spinal anesthesia” was the most commonly cited by anesthetists who refused to enroll a patient (64% of anesthetist refusals). The majority of surgeon refusals came from the USA, where surgeons preferred the patient to receive a general anesthetic. The percentage of approached parents refusing to consent ranged from a low of 3% in Italy to a high of 70% in the USA and Netherlands. The most frequently cited reason for parent refusal in all countries was a preference for general anesthesia (median: 43%, range: 32%‐67%). However, a sizeable proportion of parents in all countries had a contrasting preference for spinal anesthesia (median: 25%, range: 13%‐31%), and 23% of U.S. parents expressed concern about randomization.Conclusion: The GAS trial highlights enrollment challenges that can occur when conducting multicenter, international, pediatric studies. Investigators planning future trials should be aware of potential differences in screening processes across countries, and that exclusions by anesthetists and surgeons may vary in reason, in frequency, and by country. Furthermore, investigators should be aware that the U.S. centers encountered particularly high surgeon and parental refusal rates and that U.S. parents were uniquely concerned about randomization. Planning trials that address these difficulties should increase the likelihood of successfully recruiting subjects in pediatric trials.


  • Surgical practice and outcome in 711 neonates and infants undergoing hernia repair in a large multicenter RCT: Secondary results from the GAS Study

    by Nicola Disma, Davinia Withington, Mary Ellen McCann, Rodney Wayne Hunt, Sarah Jane Arnup, Francesca Izzo, Jurgen C. de Graaff, Girolamo Mattioli, Neil Morton, Geoff Frawley, et al.


  • Open Access

    Sample size calculations for cluster randomised crossover trials in Australian and New Zealand intensive care research

    by Sarah J. Arnup, Joanne E. McKenzie, David Pilcher, Rinaldo Bellomo, Andrew B. Forbes